Cargando…

A Developed NK-92MI Cell Line with Siglec-7(neg) Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells

Altered sialic acid processing that leads to upregulation of cell surface sialylation is recognized as a key change in malignant tissue glycosylation. This cancer-associated hypersialylation directly impacts the signaling interactions between tumor cells and their surrounding microenvironment, espec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chin-Han, Liao, Yi-Jen, Fan, Ting-Hsi, Chiou, Tzeon-Jye, Lin, Yen-Hsi, Twu, Yuh-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979288/ https://www.ncbi.nlm.nih.gov/pubmed/29617289 http://dx.doi.org/10.3390/ijms19041073

Ejemplares similares

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

A New Hope for CD56(neg)CD16(pos) NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
por: Forconi, Catherine S., et al.
Publicado: (2020)

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
por: Huang, Rih-Sheng, et al.
Publicado: (2020)

Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression
por: Cao, Wen-Jing, et al.
Publicado: (2022)

CD56(neg)CD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
por: Milush, Jeffrey M, et al.
Publicado: (2013)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Siglec-7/-9 ligands shield tumor cells from NK cell attack
por: Jandus, Camilla, et al.
Publicado: (2013)

Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion
por: Hudak, Jason E., et al.
Publicado: (2013)

Effects of total flavonoids of sea buckthorn (Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells
por: Hou, Diandong, et al.
Publicado: (2017)

Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway
por: Althaus, Jonas, et al.
Publicado: (2023)

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
por: Belisle, Jennifer A, et al.
Publicado: (2010)

Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function
por: Wang, Yuan-Hsi, et al.
Publicado: (2018)

Glucosamine prevents polarization of cytotoxic granules in NK-92 cells by disturbing FOXO1/ERK/paxillin phosphorylation
por: Božič, Janja, et al.
Publicado: (2018)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Identification of an IL-17–producing NK1.1(neg) iNKT cell population involved in airway neutrophilia
por: Michel, Marie-Laure, et al.
Publicado: (2007)

HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Wang, Yuan-Hsi, et al.
Publicado: (2019)

Unusual scalp crusted scabies in an adult T-cell leukemia/lymphoma patient
por: Lai, Yi-Chun, et al.
Publicado: (2011)

Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans
por: Rosenstock, Philip, et al.
Publicado: (2017)

β(2)-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase
por: Chiu, Wen-Chin, et al.
Publicado: (2016)

Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
por: Brauneck, Franziska, et al.
Publicado: (2021)

A NKp80-Based Identification Strategy Reveals that CD56(neg) NK Cells Are Not Completely Dysfunctional in Health and Disease
por: Orrantia, Ane, et al.
Publicado: (2020)

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
por: Romanski, Annette, et al.
Publicado: (2016)

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
por: Navarrete-Galvan, Lydia, et al.
Publicado: (2022)

Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells
por: Wang, Yuan-Hsi, et al.
Publicado: (2020)

Limited response of NK92 cells to Plasmodium falciparum-infected erythrocytes
por: de Carvalho, Elisandra Grangeiro, et al.
Publicado: (2011)

Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

CD3(+)CD4(neg)CD8(neg) (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a(+) cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis
por: Ferraz, Raquel, et al.
Publicado: (2017)

Analysis of NK-92 cytotoxicity in nasopharyngeal carcinoma cell lines and patient-derived xenografts using impedance-based growth method
por: Abd Talib, Fatin Nur Asyiqin, et al.
Publicado: (2023)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Expansion of CD56(dim)CD16(neg) NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
por: Casado, José L., et al.
Publicado: (2021)

Characteristics of Taiwanese patients of PNH in the international PNH registry
por: Chou, Wen-Chien, et al.
Publicado: (2016)

Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
por: Pinz, Kevin G., et al.
Publicado: (2017)

Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
por: Tian, Xiaopeng, et al.
Publicado: (2023)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Corrigendum: Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
por: Chrobok, Michael, et al.
Publicado: (2019)

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
por: Cao, Bihui, et al.
Publicado: (2021)

Operating/regenerating the beam screen and the NEG
por: Rossi, A
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_le6e8cv0keqv2po3bnre8le3nk